| Pancreatic Neuroendocrine Tumor studied in …STUDIED_INderived152 of 152show fewer |
|---|
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943755Phase 2/Phase 3 · recruiting Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001276recruiting Diagnosing and Treating Low Blood Sugar Levels · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924075Phase 2 · recruiting Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967951completed CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817225active not recruiting Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087054Phase 3 · recruiting Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Serotonin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165132Phase 1 · recruiting Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808879NA · recruiting Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06725693recruiting Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05687123Phase 1 · recruiting Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05997056Phase 2 · completed Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07274657NA · recruiting Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695532completed A Clinical Risk Score to Stratify High-risk PanNETs · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016855Phase 4 · recruiting Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158516Phase 2 · terminated A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619417NA · not yet recruiting Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07591493Phase 3 · not yet recruiting Adjuvant Trial in Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05988918Phase 2 · active not recruiting Multicenter Trial of ESK981 in Patients With Select Solid Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554560NA · recruiting Nutrition Intervention for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01916148available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07536087NA · recruiting Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05477576Phase 3 · recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05847855recruiting Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361668Phase 2 · completed Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Serotonin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00830557recruiting Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07439757recruiting AI-Powered Precision Decision-Making for Pancreatic Diseases · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Serotonin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03879694Phase 1 · completed Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07273409NA · recruiting Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04505553Phase 2 · completed Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328607NA · recruiting Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340437completed Clinical Study of 18F-Exendin-4 in Insulinoma · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03891784Phase 2 · active not recruiting Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735912NA · active not recruiting EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406387active not recruiting ATRX/DAXX in EUS-FNB Specimens of Pan-NETs · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663072Phase 1 · recruiting Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600233Phase 2 · active not recruiting Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05040360Phase 2 · recruiting Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159989Phase 1 · completed Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121478Phase 2 · enrolling by invitation Patients With High-grade Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121622recruiting Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02842749Phase 4 · completed Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05568017Phase 2 · terminated Neoadjuvant PRRT With Y-90-DOTATOC in pNET · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06024343NA · completed Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06557408completed Pancreatic Fistula After Minimally Invasive Enucleation · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610826Phase 1/Phase 2 · withdrawn Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041009recruiting Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02021604Phase 1 · recruiting Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02110563Phase 1 · terminated Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282059completed The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246630NA · unknown In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00970970completed Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476978completed Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01466036Phase 2 · completed Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01525082Phase 2 · completed Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03084770unknown Asymptomatic Small Pancreatic Endocrine Neoplasms. · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04452396NA · terminated CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167421NA · not yet recruiting Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264665completed OPALINE : A Study Of Morbidity And Mortality At 2 Years · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05523778NA · unknown A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06080204NA · completed Real-world Study on Adjuvant Octreotide Therapy in pNETs · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893930Phase 2 · completed Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979611Phase 1 · unknown The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05907824unknown Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427349Phase 2 · completed AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031536Phase 2 · terminated Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05171517completed Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227617Phase 2/Phase 3 · terminated Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800106Phase 1 · completed A Bioequivalence Study of Sunitinib Malate Capsules. · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05243082NA · recruiting Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03918759completed Diagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENs · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02431715no longer available 18F-FDOPA PET in Neuroendocrine Tumours · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915144Phase 2 · withdrawn 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034783early Phase 1 · unknown [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566093NA · unknown EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554744NA · unknown EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229943Phase 2 · completed Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02358356Phase 2 · completed Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03741517unknown Biomarker Study of Pancreatic Neuroendocrine Tumours · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586844completed Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147768Phase 1 · completed Laser Tissue Welding - Distal Pancreatectomy Sealing Study · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465659Phase 1/Phase 2 · completed Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Malignant Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189953Phase 1/Phase 2 · completed 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03947762terminated Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice. · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03053284Phase 2 · withdrawn Pasireotide in Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420691Phase 2 · completed Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02355535Phase 1 · completed Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02575300Phase 2 · completed Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00576680Phase 1/Phase 2 · completed RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454363Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02841865completed Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185350early Phase 1 · unknown Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134832unknown Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03053999unknown Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01648465Phase 2 · terminated Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00428220NA · completed A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03930368NA · unknown Application of Raw Corn Starch on Patients With Insulinoma · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Malignant Pancreatic Gastrinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01024387Phase 2 · completed AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03435770NA · unknown Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03417843NA · unknown Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions. · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00730483NA · terminated Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01980732no longer available 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02108782Phase 2 · withdrawn Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204019Phase 2 · unknown A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033186unknown Everolimus TDM to Predict Long Term Toxicity · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685553Phase 1 · completed Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00947167Phase 2 · terminated A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02273752Phase 2 · terminated Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01374451Phase 2 · terminated Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00804336Phase 1 · completed Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384617NA · completed Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049023Phase 1 · completed Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416767Phase 2 · completed Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02759718Phase 4 · unknown Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658436Phase 2 · completed BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01628913Phase 2 · terminated Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02624154unknown Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560376early Phase 1 · unknown 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125929NA · completed Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937079completed Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131911Phase 2 · completed Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002947Phase 1 · terminated Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01121562Phase 2 · completed Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942682Phase 1 · completed Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02121366NA · unknown EUS-guided Ethanol Ablation of an Insulinoma · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01381822Phase 1 · unknown Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02038738Phase 1/Phase 2 · unknown 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454376unknown Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602082Phase 2 · completed Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027638Phase 2 · completed Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075439Phase 2 · completed Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084461Phase 2 · terminated Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006368Phase 1 · completed Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017199Phase 2 · completed PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00434109Phase 2 · completed Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466856Phase 2 · terminated Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019786Phase 2 · completed Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005910NA · completed Laparoscopy to Remove Pancreatic Tumors (Insulinomas) · condition mapped ALIAS · 152 trials mapped (42 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |